Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AMGN

Amgen

$193.97

-1.76 (-0.90%)

09:01
09/13/19
09/13
09:01
09/13/19
09:01
Hot Stocks
Amgen says Phase 3 CANDOR study met primary endpoint »

Amgen announced the Phase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

  • 16

    Sep

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 27

    Sep

VRTX

Vertex

$172.56

-0.63 (-0.36%)

, NBIX

Neurocrine

$94.32

-0.91 (-0.96%)

04:55
09/13/19
09/13
04:55
09/13/19
04:55
Conference/Events
SVB Leerink to hold a summit »

West Coast Biopharma…

VRTX

Vertex

$172.56

-0.63 (-0.36%)

NBIX

Neurocrine

$94.32

-0.91 (-0.96%)

KURA

Kura Oncology

$16.13

-0.245 (-1.50%)

AMGN

Amgen

$193.97

-1.76 (-0.90%)

SGEN

Seattle Genetics

$70.92

0.07 (0.10%)

TPTX

Turning Point Therapeutics

$44.66

-0.355 (-0.79%)

XNCR

Xencor

$35.51

-0.77 (-2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

  • 16

    Sep

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 27

    Sep

  • 19

    Mar

Thursday
AMGN

Amgen

$194.89

-0.84 (-0.43%)

15:16
09/12/19
09/12
15:16
09/12/19
15:16
Recommendations
Amgen analyst commentary at SVB Leerink »

Amgen halt of enrollment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 16

    Sep

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 27

    Sep

AMGN

Amgen

$195.00

-0.73 (-0.37%)

15:15
09/12/19
09/12
15:15
09/12/19
15:15
Hot Stocks
Amgen says Phase 1 dose escalation clinical trial for AMG 397 on clinical hold »

Beore the market open,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 16

    Sep

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 27

    Sep

DOVA

Dova Pharmaceuticals

$15.63

-0.31 (-1.94%)

, RIGL

Rigel Pharmaceuticals

$1.66

-0.17 (-9.29%)

14:21
09/12/19
09/12
14:21
09/12/19
14:21
Conference/Events
Wedbush biotech analysts to hold a dinner meeting »

Biotech Analysts…

DOVA

Dova Pharmaceuticals

$15.63

-0.31 (-1.94%)

RIGL

Rigel Pharmaceuticals

$1.66

-0.17 (-9.29%)

ARGX

Argenx

$125.28

1.34 (1.08%)

MNTA

Momenta

$13.78

-0.295 (-2.10%)

AMGN

Amgen

$195.65

-0.08 (-0.04%)

NVS

Novartis

$89.31

0.31 (0.35%)

ALNY

Alnylam

$83.10

-3.06 (-3.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 12

    Sep

  • 16

    Sep

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 27

    Sep

  • 04

    Feb

SGEN

Seattle Genetics

$70.39

-0.46 (-0.65%)

, AZN

AstraZeneca

$42.92

-0.11 (-0.26%)

11:55
09/12/19
09/12
11:55
09/12/19
11:55
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

SGEN

Seattle Genetics

$70.39

-0.46 (-0.65%)

AZN

AstraZeneca

$42.92

-0.11 (-0.26%)

PBYI

Puma Biotechnology

$11.51

-0.37 (-3.11%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$89.02

0.02 (0.02%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 12

    Sep

  • 15

    Sep

  • 16

    Sep

  • 19

    Sep

  • 25

    Sep

  • 27

    Sep

  • 02

    Oct

  • 04

    Nov

VRTX

Vertex

$173.50

2.49 (1.46%)

, NBIX

Neurocrine

$95.23

0.14 (0.15%)

08:33
09/12/19
09/12
08:33
09/12/19
08:33
Conference/Events
SVB Leerink to hold a summit »

West Coast Biopharma…

VRTX

Vertex

$173.50

2.49 (1.46%)

NBIX

Neurocrine

$95.23

0.14 (0.15%)

KURA

Kura Oncology

$16.38

0.085 (0.52%)

AMGN

Amgen

$196.50

-0.47 (-0.24%)

SGEN

Seattle Genetics

$70.85

2.24 (3.26%)

TPTX

Turning Point Therapeutics

$45.12

2.2 (5.13%)

XNCR

Xencor

$36.28

0.64 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 12

    Sep

  • 16

    Sep

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 27

    Sep

  • 19

    Mar

SGEN

Seattle Genetics

$70.85

2.24 (3.26%)

07:42
09/12/19
09/12
07:42
09/12/19
07:42
Upgrade
Seattle Genetics rating change  »

Seattle Genetics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 12

    Sep

  • 27

    Sep

SGEN

Seattle Genetics

$70.85

2.24 (3.26%)

05:45
09/12/19
09/12
05:45
09/12/19
05:45
Upgrade
Seattle Genetics rating change at Oppenheimer »

Seattle Genetics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 12

    Sep

  • 27

    Sep

VRTX

Vertex

$173.50

2.49 (1.46%)

05:33
09/12/19
09/12
05:33
09/12/19
05:33
Hot Stocks
Vertex announces new access agreement with Scotland for Orkambi, Symkevi »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.